Do Diabetes and Genetic Polymorphisms in the COMT and OPRM1 Genes Modulate the Postoperative Opioid Demand and Pain Perception in Osteoarthritis Patients After Total Knee and Hip Arthroplasty?
Do Diabetes and Genetic Polymorphisms in the COMT and OPRM1 Genes Modulate the Postoperative Opioid Demand and Pain Perception in Osteoarthritis Patients After Total Knee and Hip Arthroplasty?
StatusVoR
Alternative title
Authors
Jurewicz, Alina
Gąsiorowska, Agata
Leźnicka, Katarzyna
Maciejewska-Skrendo, Agnieszka
Pawlak, Maciej
Machoy-Mokrzyńska, Anna
Bohatyrewicz, Andrzej
Tarnowski, Maciej
Monograph
Monograph (alternative title)
Date
2025-06-30
Publisher
Journal title
Journal of Clinical Medicine
Issue
13
Volume
14
Pages
Pages
1-20
ISSN
2077-0383
ISSN of series
Access date
2025-06-30
Abstract PL
Abstract EN
Background: Osteoarthritis (OA) of the hip and knee is a common age-related degenerative disease characterized by joint pain, stiffness, and gait disturbances. This study investigated the influence of genetic polymorphisms in the OPRM1 (rs1799971) and COMT (rs4633, rs4680, rs4818, and rs6269) genes on the postoperative analgesic requirements in 195 diabetic and non-diabetic patients undergoing total hip or knee arthroplasty. Methods: The prospective study included all patients who were admitted between January and September 2020 and agreed to participate. Postoperative pain management was assessed based on acetaminophen, ketoprofen, and morphine consumption on the first and second postoperative day. Results: Multilevel regression analyses revealed a significant three-way interaction between diabetes, type of analgesic, and OPRM1rs1799971 polymorphism, indicating different analgesic dosing patterns in diabetic and non-diabetic patients. Two-way interactions between diabetes and COMT polymorphisms rs4633, rs4680, and rs6269 further influenced the analgesic requirements. No significant associations were found for COMT rs4818. The results show that diabetes and genetic factors significantly influence opioid requirements and pain perception. Conclusions: Given the complexity of pain management in diabetic patients, personalized analgesic strategies tailored to genetic and metabolic profiles could be useful in postoperative pain management and reducing opioid consumption.
Abstract other
Keywords PL
Keywords EN
COMT
OPRM1
polymorphism
pain
postoperative treatment
opioids
diabetes
OPRM1
polymorphism
pain
postoperative treatment
opioids
diabetes
Keywords other
Exhibition title
Place of exhibition (institution)
Exhibition curator
Type
License type
Funder
Time range from
Time range to
Contact person name
Related publication
Related publication
Grant/project name
Collections
Views
4Acquisition Date31.08.2025
Downloads
2Acquisition Date31.08.2025
Altmetrics©
Dimensions
Google Scholar
